Your browser doesn't support javascript.
loading
Vascular Normalization Was Associated with Colorectal Tumor Regression upon Anti-PD-L1 Combinational Therapy.
Zhang, Yan; Gao, Jiayan; He, Yan; Qi, Ziwei; Qian, Long; Chen, Wanpei; Xu, Haiyan; Yue, Yanhua; Mao, Xunyuan; Guo, Shuxin; Zhou, Yan; Zhou, Shuru; Qin, Songbing; Zhang, Xueguang; Huang, Yuhui.
Afiliación
  • Zhang Y; The Aoyang Cancer Institute, The Affiliated Aoyang Hospital of Jiangsu University, Zhangjiagang, 215617 Jiangsu, China.
  • Gao J; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • He Y; The Aoyang Cancer Institute, The Affiliated Aoyang Hospital of Jiangsu University, Zhangjiagang, 215617 Jiangsu, China.
  • Qi Z; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Qian L; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Chen W; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Xu H; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Yue Y; Department of Anesthesiology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655 Guangdong, China.
  • Mao X; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Guo S; Department of Medical Oncology, The Second People's Hospital of Lianyungang, Lianyungang, 222000 Jiangsu, China.
  • Zhou Y; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Zhou S; Department of Hematology, The Third Affiliated Hospital of Soochow University, Changzhou, 213003 Jiangsu, China.
  • Qin S; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Zhang X; Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123 Jiangsu, China.
  • Huang Y; The Aoyang Cancer Institute, The Affiliated Aoyang Hospital of Jiangsu University, Zhangjiagang, 215617 Jiangsu, China.
J Immunol Res ; 2023: 5867047, 2023.
Article en En | MEDLINE | ID: mdl-36969495
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Linfocitos T CD8-positivos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunol Res Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Linfocitos T CD8-positivos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunol Res Año: 2023 Tipo del documento: Article País de afiliación: China